|
Re: ACC 2019 Abstracts
|
2
|
Resverlogix Corp.
|
Mar 19, 2019 01:21PM
|
|
Re: Session LBS.01 - Late Breaking Science I: Outside the Box: New Approaches to CVD Risk Reduction
|
2
|
Resverlogix Corp.
|
Nov 12, 2019 10:57AM
|
|
Re: Link for tomorrow morning late breaker results
|
2
|
Resverlogix Corp.
|
Nov 15, 2019 03:24PM
|
|
Re: New Video Out....
|
2
|
Resverlogix Corp.
|
Jun 16, 2017 10:22AM
|
|
AAIC poster
|
2
|
Resverlogix Corp.
|
Jul 14, 2019 02:36PM
|
|
Re: $1.70 close on light volume....
|
2
|
Resverlogix Corp.
|
Nov 15, 2016 04:44PM
|
|
Re: AACR 2018
|
2
|
Zenith Epigenetics
|
Mar 06, 2018 10:13AM
|
|
MD&A and Financials are posted
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jul 30, 2018 11:24PM
|
|
Re: Tundup
|
2
|
Resverlogix Corp.
|
Nov 30, 2018 01:44PM
|
|
Re: Contest Tally
|
2
|
Resverlogix Corp.
|
Feb 18, 2019 10:08PM
|
|
Re: Seeking Alpha mention
|
2
|
Resverlogix Corp.
|
Aug 23, 2019 09:02AM
|
|
Re: Breakthrough Therapy Designation Application
|
2
|
Resverlogix Corp.
|
Dec 06, 2019 09:53AM
|
|
Re: 3 point MACE vs 5 point MACE
|
2
|
Resverlogix Corp.
|
Nov 02, 2018 02:54PM
|
|
Re: Help on Short Interest Please
|
2
|
Resverlogix Corp.
|
Mar 07, 2019 01:58PM
|
|
Re: AE/LFT concerns
|
2
|
Resverlogix Corp.
|
Nov 16, 2019 08:51PM
|
|
Re: Zenith AGM webcast 9/12/2018
|
2
|
Zenith Epigenetics
|
Sep 12, 2018 01:59PM
|
|
The Faces of Cardiovascular Disease: Part 3
|
2
|
Resverlogix Corp.
|
Apr 02, 2019 02:37PM
|
|
Resverlogix Announces Publication on Apabetalone in High-Impact American Journal of Respiratory and Critical Care Medicine (AJRCCM)
|
2
|
Resverlogix Corp.
|
May 06, 2019 09:12AM
|
|
Re: Dr Sweeney
|
2
|
Resverlogix Corp.
|
Jun 22, 2016 12:12PM
|
|
Re: Why is it taking so long Simple.
|
2
|
Resverlogix Corp.
|
Apr 17, 2019 05:40PM
|
